Myorisan (VersaPharm Incorporated)


Welcome to the PulseAid listing for the Myorisan drug offered from VersaPharm Incorporated. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: VersaPharm Incorporated
NON-PROPRIETARY NAME: isotretinoin
SUBSTANCE NAME: ISOTRETINOIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Retinoid [EPC],Retinoids [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, LIQUID FILLED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-05-01
END MARKETING DATE: 0000-00-00


Myorisan HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMyorisan from VersaPharm Incorporated
LABELER NAME: VersaPharm Incorporated
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2012-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61748-301_8a1a1438-cbda-4fa4-b74a-eb3caeacbd3f
PRODUCT NDC: 61748-301
APPLICATION NUMBER: ANDA076485

Other ISOTRETINOIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal Pharmaceuticals LLCIsotretinoin
Dr. Reddy’s Laboratories LimitedZENATANE
Mylan Pharmaceuticals Inc.Amnesteem
Physicians Total Care, Inc.Claravis
Ranbaxy Laboratories Inc.Absorica
Teva Pharmaceuticals USA, Inc.Claravis
VersaPharm IncorporatedMyorisan